« Nationwide Voluntary Recall of a Single Manufacturing Lot (Lot 558470A) of Azathioprine Tablets in the U.S. and Puerto Rico Initiated by Roxane Lab, Inc. | Main | Nabi Biopharmaceuticals’ Nabi-HB™ Intravenous Received Positive Opinion from USFDA Blood Products Advisory Committee (BPAC) »

Jul18
Vectomega®, A Revolutionary Omega-3 Phospholipid Complex (DHA/EPA) Showed Positive Health Benefits in Preliminary Human Clinical Trial

produit-Vectomega.gifVectomega® is a revolutionary Omega-3 phospholipid complex with DHA/EPA which EuroPharma has obtained North American distribution rights of.

This product is molecularly different from other omega-3’s currently on the market because this is 50 times more absorbable across cellular membranes than other DHA/EPA products and is available as a water/oil soluble powder.

In a recent human trial by French doctors demonstrated that only 2 tablets per day of Vectomega® improve cardiovascular health by reducing cholesterol, triglycerides and increasing HDL-c in a healthy population, among other benefits.

Vectomega® is a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as theyoccur in nature.

Vectomega® uses a biological innovation that extracts naturally occurring marine phospholipids with the omega-3 fatty acids, EPA and DHA. Standard fish oil products do not contain these marine phospholipids.

This patented innovation, called vectorization, uses a gentle, cold water and enzyme process avoiding heat, solvents, and chemical modifications unlike the process utilized by standard fish oil products.

Read more at EuroPharma (a pdf file).

related entries


1 Comments/Trackbacks




How do I order Vectomega

submit a trackback

TrackBack URL for this entry:

post a comment

Name, Email Address, and URL are not required fields.





Comment Preview

« Nationwide Voluntary Recall of a Single Manufacturing Lot (Lot 558470A) of Azathioprine Tablets in the U.S. and Puerto Rico Initiated by Roxane Lab, Inc. | Main | Nabi Biopharmaceuticals’ Nabi-HB™ Intravenous Received Positive Opinion from USFDA Blood Products Advisory Committee (BPAC) »

Advertise

Watch the Digital Health Revolution


sponsored ads



subscribe


Prefer Email?
Subscribe below-

Enter your Email:


Powered by FeedBlitz What's this?

Current News

Support This Blog

top blogs

business social media

Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

BIZZlogos - Add your logo - free link to your site
BIZZphotos - Add photos of your products and people
BIZZprofiles - Submit your profile and build your online visibility
BIZZspotlight - Spotlight your business with free links
BIZZvideos - Videos about businesses, products and business people.
BIZZbites - "Digg" for Business - Submit your articles and posts

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed


we support unitus

PRWeb

Influencer



PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

BrainBasedBusiness

TheInsurancePolicy

MarketingBlurb